Literature DB >> 9371620

Naked DNA vaccines expressing the prM and E genes of Russian spring summer encephalitis virus and Central European encephalitis virus protect mice from homologous and heterologous challenge.

C Schmaljohn1, L Vanderzanden, M Bray, D Custer, B Meyer, D Li, C Rossi, D Fuller, J Fuller, J Haynes, J Huggins.   

Abstract

Naked DNA vaccines expressing the prM and E genes of two tick-borne flaviviruses, Russian spring summer encephalitis (RSSE) virus and Central European encephalitis (CEE) virus were evaluated in mice. The vaccines were administered by particle bombardment of DNA-coated gold beads by Accell gene gun inoculation. Two immunizations of 0.5 to 1 microg of RSSE or CEE constructs/dose, delivered at 4-week intervals, elicited cross-reactive antibodies detectable by enzyme-linked immunosorbent assay and high-titer neutralizing antibodies to CEE virus. Cross-challenge experiments demonstrated that either vaccine induced protective immunity to homologous or heterologous RSSE or CEE virus challenge. The absence of antibody titer increases after challenge and the presence of antibodies to E and prM, but not NS1, both before and after challenge suggest that the vaccines prevented productive replication of the challenge virus. One vaccination with 0.5 microg of CEE virus DNA provided protective immunity for at least 2 months, and two vaccinations protected mice from challenge with CEE virus for at least 6 months.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9371620      PMCID: PMC230264     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  Recombinant vaccinia virus producing the prM and E proteins of yellow fever virus protects mice from lethal yellow fever encephalitis.

Authors:  S Pincus; P W Mason; E Konishi; B A Fonseca; R E Shope; C M Rice; E Paoletti
Journal:  Virology       Date:  1992-03       Impact factor: 3.616

2.  Molecular epidemiology of tick-borne encephalitis virus: cross-protection between European and Far Eastern subtypes.

Authors:  H Holzmann; M S Vorobyova; I P Ladyzhenskaya; E Ferenczi; M Kundi; C Kunz; F X Heinz
Journal:  Vaccine       Date:  1992       Impact factor: 3.641

3.  Characterization of tick-borne encephalitis virus and immunogenicity of its surface components in mice.

Authors:  F Heinz; C Kunz
Journal:  Acta Virol       Date:  1977-07       Impact factor: 1.162

4.  Antigenic relationships between flaviviruses as determined by cross-neutralization tests with polyclonal antisera.

Authors:  C H Calisher; N Karabatsos; J M Dalrymple; R E Shope; J S Porterfield; E G Westaway; W E Brandt
Journal:  J Gen Virol       Date:  1989-01       Impact factor: 3.891

5.  Mice immunized with a subviral particle containing the Japanese encephalitis virus prM/M and E proteins are protected from lethal JEV infection.

Authors:  E Konishi; S Pincus; E Paoletti; R E Shope; T Burrage; P W Mason
Journal:  Virology       Date:  1992-06       Impact factor: 3.616

6.  A topological and functional model of epitopes on the structural glycoprotein of tick-borne encephalitis virus defined by monoclonal antibodies.

Authors:  F X Heinz; R Berger; W Tuma; C Kunz
Journal:  Virology       Date:  1983-04-30       Impact factor: 3.616

7.  Immunogenicity and reactogenicity of a highly purified vaccine against tick-borne encephalitis.

Authors:  C Kunz; F X Heinz; H Hofmann
Journal:  J Med Virol       Date:  1980       Impact factor: 2.327

Review 8.  The skin as an organ of immunity.

Authors:  J D Bos
Journal:  Clin Exp Immunol       Date:  1997-01       Impact factor: 4.330

9.  Molecular characterization of a neutralizing domain of the Japanese encephalitis virus structural glycoprotein.

Authors:  P W Mason; J M Dalrymple; M K Gentry; J M McCown; C H Hoke; D S Burke; M J Fournier; T L Mason
Journal:  J Gen Virol       Date:  1989-08       Impact factor: 3.891

10.  Japanese encephalitis virus-vaccinia recombinants produce particulate forms of the structural membrane proteins and induce high levels of protection against lethal JEV infection.

Authors:  P W Mason; S Pincus; M J Fournier; T L Mason; R E Shope; E Paoletti
Journal:  Virology       Date:  1991-01       Impact factor: 3.616

View more
  30 in total

1.  Evaluation of immunoglobulin M (IgM) and IgG enzyme immunoassays in serologic diagnosis of West Nile Virus infection.

Authors:  G Tardei; S Ruta; V Chitu; C Rossi; T F Tsai; C Cernescu
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

2.  Tick-borne Encephalitis Vaccines.

Authors:  Axel T Lehrer; Michael R Holbrook
Journal:  J Bioterror Biodef       Date:  2011

3.  The anamnestic neutralizing antibody response is critical for protection of mice from challenge following vaccination with a plasmid encoding the Japanese encephalitis virus premembrane and envelope genes.

Authors:  E Konishi; M Yamaoka; I Kurane; K Takada; P W Mason
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

4.  Construction and nonclinical testing of a Puumala virus synthetic M gene-based DNA vaccine.

Authors:  R L Brocato; M J Josleyn; V Wahl-Jensen; C S Schmaljohn; J W Hooper
Journal:  Clin Vaccine Immunol       Date:  2012-12-12

5.  Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes.

Authors:  A G Pletnev; M Bray; K A Hanley; J Speicher; R Elkins
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

6.  DNA vaccination with the Hantaan virus M gene protects Hamsters against three of four HFRS hantaviruses and elicits a high-titer neutralizing antibody response in Rhesus monkeys.

Authors:  J W Hooper; D M Custer; E Thompson; C S Schmaljohn
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

7.  Production of pseudoinfectious yellow fever virus with a two-component genome.

Authors:  Alexandr V Shustov; Peter W Mason; Ilya Frolov
Journal:  J Virol       Date:  2007-08-22       Impact factor: 5.103

8.  Immunization of woodchucks with plasmids expressing woodchuck hepatitis virus (WHV) core antigen and surface antigen suppresses WHV infection.

Authors:  M Lu; G Hilken; J Kruppenbacher; T Kemper; R Schirmbeck; J Reimann; M Roggendorf
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

9.  Active and passive vaccination against hantavirus pulmonary syndrome with Andes virus M genome segment-based DNA vaccine.

Authors:  D M Custer; E Thompson; C S Schmaljohn; T G Ksiazek; J W Hooper
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

10.  The relative contribution of antibody and CD8+ T cells to vaccine immunity against West Nile encephalitis virus.

Authors:  Bimmi Shrestha; Terry Ng; Hsien-Jue Chu; Michelle Noll; Michael S Diamond
Journal:  Vaccine       Date:  2008-02-20       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.